David Wheadon - Jun 16, 2021 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
Director
Signature
/s/ Margaret Echerd, Attorney-in-Fact for David Wheadon
Stock symbol
VXRT
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 07:29 PM
Previous filing
Jun 1, 2021
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +65.7K $0.00 65.7K Jun 16, 2021 Common stock 65.7K $6.54 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted by the board of directors of Vaxart, Inc. effective on May 10, 2021, subject to stockholder approval of an amendment to the Vaxart, Inc. 2019 Equity Incentive Plan, under which the stock option was granted. Vaxart, Inc.'s stockholders approved the plan amendment on June 16, 2021.
F2 The shares subject to this option shall vest annually over three years from the vesting commencement date of April 21, 2021, the date of the grantee's appointment as a director of Vaxart, Inc.